Status:
UNKNOWN
Postpartum Intra-caesarean Intrauterine Device Insertion Using a Novel Technique
Lead Sponsor:
Assiut University
Conditions:
IUD Complication
Eligibility:
FEMALE
18-45 years
Brief Summary
The assessment of efficacy and patient safety of immediate postpartum IUD insertion using a novel technique.
Detailed Description
The postpartum period is so critical time for both the mother and newborn that needs special health care because there are high morbidity and mortality rates during it (1). The World Health Organizat...
Eligibility Criteria
Inclusion
- Women admitted to undergo CS.
- Singleton pregnancy.
- Delivery of a liveـborn infant with gestational age \< 36 weeks.
- Informed and written consent to participate in the study.
Exclusion
- History of dysmenorrhea, menorrhagia or coagulopathies.
- Uterine anomalies or fibroids.
- Antepartum or intrapartum hemorrhage.
- Prolonged rupture of membranes \<24 hours with or without chorioamnionitis.
- Intrapartum fever.
- History of current, recent (within previous 3 months) or recurrent pelvic infilammatory diseases (PID).
- History of ectopic pregnancy.
- Multiple pregnancy.
- Active cervicitis, vaginitis or sexual transmitted diseases (STD) on gyaecological examination.
- Allergy to any component of the IUD or Wilson's disease.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04718337
Start Date
June 1 2021
End Date
July 1 2022
Last Update
January 22 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.